Table 1 Patient Characteristics
Mitral regurgitation | Tricuspid regurgitation | All | p-value | |
|---|---|---|---|---|
(n = 18) | (n = 26) | (n = 44) | ||
Age (years) | 12.6 ± 7.8 | 10.7 ± 5.0 | 11.4 ± 6.3 | 0.370 |
Sex (F) | 8 (44%) | 15 (58%) | 23 (52%) | 0.387 |
Race | ||||
Caucasian | 9 (50%) | 8 (31%) | 17 (39%) | 0.543 |
African American | 1 (4%) | 1 (2%) | ||
Hispanic | 6 (33%) | 11 (42%) | 17 (39%) | |
Asian | 3 (17%) | 6 (23%) | 9 (20%) | |
Height (cm) | 141.6 ± 36.3 | 133.7 ± 28.4 | 136.9 ± 31.7 | 0.420 |
Weight (kg) | 49.2 ± 32.2 | 43.2 ± 34.0 | 45.7 ± 33.0 | 0.562 |
Aliasing of the jet | 12 (67%) | 11 (42%) | 23 (52%) | 0.112 |
Number of regurgitant jets | ||||
1 | 13 (72%) | 21 (81%) | 34 (77%) | 0.654 |
2 | 3 (17%) | 4 (15%) | 7 (16%) | |
3 | 1 (6%) | 1 (4%) | 2 (5%) | |
5 | 1 (6%) | 1 (2%) | ||
Regurgitation | ||||
Mild (< 30%) | 13 (72%) | 14 (54%) | 27 (61%) | 0.140 |
Moderate (31–39%) | 3 (11%) | 3 (7%) | ||
Moderate-Severe (40–49%) | 1 (6%) | 6 (23%) | 7 (16%) | |
Severe (> 50%) | 4 (22%) | 3 (11%) | 7 (16%) | |
Cardiac Condition | ||||
Bacterial endocarditis | 2 (11%) | 2 (5%) | ||
ccTGA | 1 (6%) | 2 (8%) | 3 (7%) | |
Atrioventricular septal defect | 5 (28%) | 1 (4%) | 6 (14%) | |
Dysplastic tricuspid valve | 1 (4%) | 1 (2%) | ||
Ebstein anomaly | 8 (31%) | 8 (18%) | ||
HLHS s/p Glenn | 2 (8%) | 2 (5%) | ||
HLHS s/p Fontan | 4 (15%) | 4 (9%) | ||
HOCM | 1 (6%) | 1 (2%) | ||
PA/IVS s/p Fontan | 1 (6%) | 1 (2%) | ||
Mitral Valve Prolapse | 6 (34%) | 6 (14%) | ||
Pulmonary hypertension | 7 (27%) | 7 (16%) | ||
Pulmonary stenosis | 1 (4%) | 1 (2%) | ||
Shone complex | 1 (6%) | 1 (2%) | ||
Supramitral ring | 1 (6%) | 1 (2%) | ||
Shunt ratio (Qp:Qs) | 1.0 ± 0.08 | 0.97 ± 0.11 | 0.98 ± 0.10 | 0.956 |
Genetic syndromes | ||||
Marfan Syndrome | 2 (11%) | 1 (4%) | 3 (7%) | |
Pierre Robin syndrome | 1 (6%) | 1 (2%) | ||
Trisomy 21 | 1 (6%) | 1 (2%) | ||
Turner syndrome | 1 (4%) | 1 (2%) | ||
Field Strength | ||||
1.5 T | 8 (44%) | 17 (65%) | 25 (57%) | 0.168 |
3 T | 10 (56%) | 9 (35%) | 19 (43%) | |
Contrast | ||||
Gadobenate | 5 (27%) | 11 (42%) | 16 (36%) | 0.200 |
Gadofosveset | 1 (6%) | 4 (15%) | 5 (11%) | |
Ferumoxytol | 9 (50%) | 11 (42%) | 20 (45%) | |
No contrast | 1 (6%) | 1 (2%) | ||